medigraphic.com
ISSN 1561-3194 (Electronic)

2015, Number 5

<< Back Next >>

Rev Ciencias Médicas 2015; 19 (5)

The interaction of genome and environment with hypertension

Moreno PLM, Lardoeyt FR, Iglesias RMB, Padilla PJ

Language: Spanish
References: 20
Page: 853-867
PDF size: 208.05 Kb.


ABSTRACT

Introduction: hypertension has a multi-factorial origin in which genetic and environmental factors play an important role, and it is one of the most important health care problems in contemporary medicine. In Cuba the study to find out the interaction of genetic predisposition along with the environmental factors is a challenge.
Objective: to evaluate the interaction of a predisposing genome with adverse environmental factors in the development of this disease.
Material and methods: a case-control study was designed, taking the population of the 19 de abril Polyclinic, in Plaza de la Revolución municipality between the years 2012 and 2014. The sample was comprised of 80 cases and 160 controls, obtained by simple random sampling, environmental factors and genetic risks were assessed, as well as the parental origin for genetic predisposition.
Results: it was found that pathological alcohol consumption, low physical activity; overweight, sugar-rich and low-vegetable diets increase the risk of developing hypertension. Maternal origin of the disease predominated. The interaction of a predisposing genome given by first-degree family history and environmental factors such as obesity increase the probability of developing hypertension.
Conclusions: adverse environmental factors tend to modulate the genetic predisposition of a predisposing genome for the development of the disease.


REFERENCES

  1. Sellén Crombet J. Hipertensión arterial: diagnóstico, tratamiento y control. Tesis presentada en opción al grado científico de Doctor en Ciencias Médicas. Ciudad de La Habana: Universidad de Ciencias Médicas de la Habana; 2007.

  2. Herrera A FD. Hipertensión arterial y riesgo cardiovascular global. Revista Cubana de Cardiología y Cirugía Cardiovascular. 2014; 19(3-4):119-20.

  3. Ducongé Munárriz Y. Influencia de factores genéticos y ambientales en el desarrollo de la Hipertensión Arterial en el municipio Plaza de Ciudad Habana. Revista Cubana de Genética Comunitaria. 2009; 3(1):26-30.

  4. Dueñas Herrera A. La hipertensión arterial. Revista Cubana de Medicina. 2011; 50(3): 232-3.4

  5. Ledesma MS. Hipertensión arterial e inflamación: Análisis de polimorfismos genéticos y su correlación clínica y biológica: Ediciones Universidad de Salamanca; 2014.

  6. Quiroga de Michelena MI. Hipertensión arterial -Aspectos genéticos. An Fac med. 2010; 71(4): 231-5.

  7. Falkner B, Cossrow ND. Prevalence of metabolic syndrome and obesity-associated hypertension in the racial ethnic minorities of the United States. Curr Hypertens Rep. 2014; 16(7): 449.

  8. Estany ER, Sarduy JDB, Machado RR, Vilar MN, Gómez JAA, Valdés FF. Consenso Corazón y Diabetes: Ejercicios Físicos en Pacientes Diabéticos con Enfermedades Cardiovasculares. Revista Cubana de Cardiología y Cirugía Cardiovascular. 2011; 17(4): 328-34.

  9. González RH, Estany ER, Hernández IN, Gómez JA. Papel del especialista en ejercicio físico en el programa de rehabilitación cardíaca. Revista Cubana de Cardiología y Cirugía Cardiovascular. 2014; 14(1).

  10. Weidmann P, Boehlen LM, de Courten M. Pathogenesis and treatment of hypertension associated with diabetes mellitus. American heart journal. 1993; 125(5): 1498-513.

  11. Thanassoulis G, Lyass A, Benjamin EJ, Larson MG, Vita JA, Levy D, et al. Relations of exercise blood pressure response to cardiovascular risk factors and vascular function in the Framingham Heart Study. Circulation. 2012; 125(23): 2836-43.

  12. Dalai N, Cui H, Yan M, Rile G, Li S, Su X. Risk factors for the development of essential hypertension in a Mongolian population of China: a case-control study. Genetics and molecular research: GMR. 2014; 13(2): 3283-91.

  13. Kopec W, Loubet B, Poulsen H, Khandelia H. Molecular mechanism of Na(+),K(+)- ATPase malfunction in mutations characteristic of adrenal hypertension. Biochemistry. 2014; 53(4): 746-54.

  14. Hullar MA, Fu BC. Diet, the gut microbiome, and epigenetics. Cancer journal. 2014; 20(3): 170-5.

  15. Martinez JA, Milagro FI, Claycombe KJ, Schalinske KL. Epigenetics in adipose tissue, obesity, weight loss, and diabetes. Advances in nutrition. 2014; 5(1): 71-81.

  16. Marchi KC, Muniz JJ, Tirapelli CR. Hypertension and chronic ethanol consumption: What do we know after a century of study? World journal of cardiology. 2014; 6(5): 283-94.

  17. Hawley NL, Minster RL, Weeks DE, Viali S, Reupena MS, Sun G, et al. Prevalence of adiposity and associated cardiometabolic risk factors in the samoan genome-wide association study. American journal of human biology: the official journal of the Human Biology Council. 2014; 26(4): 491-501.

  18. De Stefano AL, Gavras H, Herad-Costa N, Bursztyn M, Manolis A, Farrer LA, et al. Maternal component in the familial aggregation of hypertension. Clin Genet. 2001; 60(1): 13-21.

  19. Fermino R, Seabra C, Garganta R, Ribeiro A. Factores genéticos en la agregación familiar de la presión arterial de familias nucleares portuguesas. Arq Bras Cardiol. 2009; 92(3): 41-49.

  20. Jermendy G, Horváth T, Littvay L, Steinbach R, Jermendy ÁL, Tárnoki ÁD, et al. Effect of genetic and environmental influences on cardiometabolic risk factors: a twin study. Cardiovasc Diabetol. 2011; 10: 96.




2020     |     www.medigraphic.com